These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 28716904)

  • 1. Intracellular zinc activates KCNQ channels by reducing their dependence on phosphatidylinositol 4,5-bisphosphate.
    Gao H; Boillat A; Huang D; Liang C; Peers C; Gamper N
    Proc Natl Acad Sci U S A; 2017 Aug; 114(31):E6410-E6419. PubMed ID: 28716904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of Kv7 (KCNQ) K+ channel open probability by phosphatidylinositol 4,5-bisphosphate.
    Li Y; Gamper N; Hilgemann DW; Shapiro MS
    J Neurosci; 2005 Oct; 25(43):9825-35. PubMed ID: 16251430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic interplay of Gβγ and phosphatidylinositol 4,5-bisphosphate dictates Kv7.4 channel activity.
    Povstyan OV; Barrese V; Stott JB; Greenwood IA
    Pflugers Arch; 2017 Feb; 469(2):213-223. PubMed ID: 27981364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zinc pyrithione-mediated activation of voltage-gated KCNQ potassium channels rescues epileptogenic mutants.
    Xiong Q; Sun H; Li M
    Nat Chem Biol; 2007 May; 3(5):287-96. PubMed ID: 17435769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural Determinants of Kv7.5 Potassium Channels That Confer Changes in Phosphatidylinositol 4,5-Bisphosphate (PIP
    Brueggemann LI; Cribbs LL; Byron KL
    Mol Pharmacol; 2020 Mar; 97(3):145-158. PubMed ID: 31871302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II regulates neuronal excitability via phosphatidylinositol 4,5-bisphosphate-dependent modulation of Kv7 (M-type) K+ channels.
    Zaika O; Lara LS; Gamper N; Hilgemann DW; Jaffe DB; Shapiro MS
    J Physiol; 2006 Aug; 575(Pt 1):49-67. PubMed ID: 16777936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combinatorial augmentation of voltage-gated KCNQ potassium channels by chemical openers.
    Xiong Q; Sun H; Zhang Y; Nan F; Li M
    Proc Natl Acad Sci U S A; 2008 Feb; 105(8):3128-33. PubMed ID: 18272489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel KCNQ4 variants in different functional domains confer genotype- and mechanism-based therapeutics in patients with nonsyndromic hearing loss.
    Lee SY; Choi HB; Park M; Choi IS; An J; Kim A; Kim E; Kim N; Han JH; Kim MY; Lee SM; Oh DY; Kim BJ; Yi N; Kim NKD; Lee C; Park WY; Koh YI; Gee HY; Cho HS; Kang TM; Choi BY
    Exp Mol Med; 2021 Jul; 53(7):1192-1204. PubMed ID: 34316018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. M channel enhancers and physiological M channel block.
    Linley JE; Pettinger L; Huang D; Gamper N
    J Physiol; 2012 Feb; 590(4):793-807. PubMed ID: 22155935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphatidylinositol 4,5-bisphosphate (PIP
    Choveau FS; De la Rosa V; Bierbower SM; Hernandez CC; Shapiro MS
    J Biol Chem; 2018 Dec; 293(50):19411-19428. PubMed ID: 30348901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A change in configuration of the calmodulin-KCNQ channel complex underlies Ca2+-dependent modulation of KCNQ channel activity.
    Kosenko A; Hoshi N
    PLoS One; 2013; 8(12):e82290. PubMed ID: 24349250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural insights into the lipid and ligand regulation of a human neuronal KCNQ channel.
    Zheng Y; Liu H; Chen Y; Dong S; Wang F; Wang S; Li GL; Shu Y; Xu F
    Neuron; 2022 Jan; 110(2):237-247.e4. PubMed ID: 34767770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiological and pharmacological characterization of a novel and potent neuronal Kv7 channel opener SCR2682 for antiepilepsy.
    Zhang F; Liu Y; Tang F; Liang B; Chen H; Zhang H; Wang K
    FASEB J; 2019 Aug; 33(8):9154-9166. PubMed ID: 31063701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein arginine methylation facilitates KCNQ channel-PIP2 interaction leading to seizure suppression.
    Kim HJ; Jeong MH; Kim KR; Jung CY; Lee SY; Kim H; Koh J; Vuong TA; Jung S; Yang H; Park SK; Choi D; Kim SH; Kang K; Sohn JW; Park JM; Jeon D; Koo SH; Ho WK; Kang JS; Kim ST; Cho H
    Elife; 2016 Jul; 5():. PubMed ID: 27466704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminoglycosides inhibit KCNQ4 channels in cochlear outer hair cells via depletion of phosphatidylinositol(4,5)bisphosphate.
    Leitner MG; Halaszovich CR; Oliver D
    Mol Pharmacol; 2011 Jan; 79(1):51-60. PubMed ID: 20935082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic PIP2 interactions with voltage sensor elements contribute to KCNQ2 channel gating.
    Zhang Q; Zhou P; Chen Z; Li M; Jiang H; Gao Z; Yang H
    Proc Natl Acad Sci U S A; 2013 Dec; 110(50):20093-8. PubMed ID: 24277843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Competition of calcified calmodulin N lobe and PIP2 to an LQT mutation site in Kv7.1 channel.
    Tobelaim WS; Dvir M; Lebel G; Cui M; Buki T; Peretz A; Marom M; Haitin Y; Logothetis DE; Hirsch JA; Attali B
    Proc Natl Acad Sci U S A; 2017 Jan; 114(5):E869-E878. PubMed ID: 28096388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphatidylinositol 4,5-bisphosphate alters pharmacological selectivity for epilepsy-causing KCNQ potassium channels.
    Zhou P; Yu H; Gu M; Nan FJ; Gao Z; Li M
    Proc Natl Acad Sci U S A; 2013 May; 110(21):8726-31. PubMed ID: 23650395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing the regulation of M (Kv7) potassium channels in intact neurons with membrane-targeted peptides.
    Robbins J; Marsh SJ; Brown DA
    J Neurosci; 2006 Jul; 26(30):7950-61. PubMed ID: 16870740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A PIP
    Liu Y; Xu X; Gao J; Naffaa MM; Liang H; Shi J; Wang HZ; Yang ND; Hou P; Zhao W; White KM; Kong W; Dou A; Cui A; Zhang G; Cohen IS; Zou X; Cui J
    Commun Biol; 2020 Jul; 3(1):385. PubMed ID: 32678288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.